EAS 2022 — CVD prevention beyond pharmacotherapy

Pavankumar Kamat | Conference Report | 27 May 2022

Experts discuss certain atypical aspects of CVD prevention.

In a plenary session at EAS 2022 titled 'From lifestyle to designer therapies' chaired by Christoph J. Binder, Austria and Maciej Banach, Poland, experts discussed certain aspects of cardiovascular disease (CVD) prevention beyond pharmacotherapy.

CVD prevention at population level (Salim Yusuf, Canada)

The three major modifiable causes of vascular mortality...

EAS 2022 — CVD prevention beyond pharmacotherapy

March Challenge

What is the gold standard lab test for Mpox?

Which of the following is true regarding hyperparathyroidism?

What is the nonpsychiatric side of peripartum suicide?

Which region in the world has the highest concentration of people with hearing loss?

What is the leading cause of death in low-income countries?

Which of these bacterial species can cause a tick-borne relapsing fever?

What are the causes of an adult-acquired flatfoot deformity?

Are Listeria outbreaks linked to imported food items?

What is the most common condition for foetal stillbirths in South Asia?

How to classify nasoorbitoethmoid fractures?

Hypertension: How safe is your sight?

What are the risk factors for age-related macular degeneration?

How do you therapeutically manage inferiority complex disorder?

What are the causes of intrinsic restrictive lung diseases?

What do we know about acute flaccid paralysis?

What is not a criterion in the ADA risk scoring for thrombosis in patients with COVID-19?

What pathology can alpha-synuclein malformation cause?

Which of the following is not true about diabetic nephropathy?

Which is not a policy document of the World Medical Association?

What is not a contraceptive option for women at high risk for HIV infection?

What is an anterior and posterior approach for cervical spondylotic myelopathy?

Which beta-blocker is more suitable for managing LQTS and CPVT?

Chapare virus is endemic to which of the following countries?

Which mutation is responsible for Klippel-Trénaunay syndrome?

Can you identify the right GOLD grade for a patient with COPD?

Topic Challenges

Quiz challenge Emerging diseases: COVID-19

ESMO 2020 topic challenge

Women's health challenge

Antibiotics - Consequence of MDR carriage

Neurological disorders challenge

Rheumatology challenge

Lyme Disease

Mental health challenge

Topic challenge - Children conditions

Lyme Disease